Alpha-fetoprotein detection of hepatocellular carcinoma leads to a standardized analysis of dynamic AFP to improve screening based detection

Thomas G. Bird, Polyxeni Dimitropoulou, Rebecca M. Turner, Sara J. Jenks, Pearce Cusack, Shiying Hey, Andrew Blunsum, Sarah Kelly, Catharine Sturgeon, Peter C. Hayes, Sheila M. Bird

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Detection of hepatocellular carcinoma (HCC) through screening can improve outcomes. However, HCC surveillance remains costly, cumbersome and suboptimal. We tested whether and how serum Alpha-Fetoprotein (AFP) should be used in HCC surveillance. Record linkage, dedicated pathways for management and AFP data-storage identified i) consecutive highly characterised cases of HCC diagnosed in 2009-14 and ii) a cohort of ongoing HCC-free patients undergoing regular HCC surveillance from 2009. These two well-defined Scottish patient cohorts enabled us to test the utility of AFP surveillance. Of 04 cases of HCC diagnosed over 6 years, 42% (129) were identified by a dedicated HCC surveillance programme. Of these 129, 47% (61) had a detectable lesion first identified by screening ultrasound (US) but 38% (49) were prompted by elevated AFP. Despite pre-HCC diagnosis AFP >20kU/L being associated with poor outcome, 'AFP-detected' tumours were offered potentially curative management as frequently as 'US-detected' HCCs; and had comparable survival. Linearity of serial log10 -transformed AFPs in HCC cases and in the screening 'HCC-free' cohort (n = 1509) provided indicators of high-risk AFP behaviour in HCC cases. An algorithm was devised in static mode, then tested dynamically. A case/control series in hepatitis C related disease demonstrated highly significant detection (p-5) of patients at high risk of developing HCC. These data support the use of AFP in HCC surveillance. We show proof-of-principle that an automated and further refineable algorithmic interpretation of AFP can identify patients at higher risk of HCC. This approach could provide a cost-effective, user-friendly and much needed addition to US surveillance.

LanguageEnglish
Article numbere0156801
Number of pages22
JournalPLOS One
Volume11
Issue number6
DOIs
Publication statusPublished - 1 Jun 2016

Fingerprint

alpha-Fetoproteins
hepatoma
Hepatocellular Carcinoma
Screening
screening
monitoring
Ultrasonics
Tumors
hepatitis C
Information Storage and Retrieval
Data storage equipment
Hepatitis C

Keywords

  • Alpha-Fetoprotein detection (AFP)
  • hepatocellular carcinoma (HCC)
  • HCC surveillance

Cite this

Bird, Thomas G. ; Dimitropoulou, Polyxeni ; Turner, Rebecca M. ; Jenks, Sara J. ; Cusack, Pearce ; Hey, Shiying ; Blunsum, Andrew ; Kelly, Sarah ; Sturgeon, Catharine ; Hayes, Peter C. ; Bird, Sheila M. / Alpha-fetoprotein detection of hepatocellular carcinoma leads to a standardized analysis of dynamic AFP to improve screening based detection. In: PLOS One. 2016 ; Vol. 11, No. 6.
@article{785a3ee2e48e40e8b229c9ec1d226203,
title = "Alpha-fetoprotein detection of hepatocellular carcinoma leads to a standardized analysis of dynamic AFP to improve screening based detection",
abstract = "Detection of hepatocellular carcinoma (HCC) through screening can improve outcomes. However, HCC surveillance remains costly, cumbersome and suboptimal. We tested whether and how serum Alpha-Fetoprotein (AFP) should be used in HCC surveillance. Record linkage, dedicated pathways for management and AFP data-storage identified i) consecutive highly characterised cases of HCC diagnosed in 2009-14 and ii) a cohort of ongoing HCC-free patients undergoing regular HCC surveillance from 2009. These two well-defined Scottish patient cohorts enabled us to test the utility of AFP surveillance. Of 04 cases of HCC diagnosed over 6 years, 42{\%} (129) were identified by a dedicated HCC surveillance programme. Of these 129, 47{\%} (61) had a detectable lesion first identified by screening ultrasound (US) but 38{\%} (49) were prompted by elevated AFP. Despite pre-HCC diagnosis AFP >20kU/L being associated with poor outcome, 'AFP-detected' tumours were offered potentially curative management as frequently as 'US-detected' HCCs; and had comparable survival. Linearity of serial log10 -transformed AFPs in HCC cases and in the screening 'HCC-free' cohort (n = 1509) provided indicators of high-risk AFP behaviour in HCC cases. An algorithm was devised in static mode, then tested dynamically. A case/control series in hepatitis C related disease demonstrated highly significant detection (p-5) of patients at high risk of developing HCC. These data support the use of AFP in HCC surveillance. We show proof-of-principle that an automated and further refineable algorithmic interpretation of AFP can identify patients at higher risk of HCC. This approach could provide a cost-effective, user-friendly and much needed addition to US surveillance.",
keywords = "Alpha-Fetoprotein detection (AFP), hepatocellular carcinoma (HCC), HCC surveillance",
author = "Bird, {Thomas G.} and Polyxeni Dimitropoulou and Turner, {Rebecca M.} and Jenks, {Sara J.} and Pearce Cusack and Shiying Hey and Andrew Blunsum and Sarah Kelly and Catharine Sturgeon and Hayes, {Peter C.} and Bird, {Sheila M.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1371/journal.pone.0156801",
language = "English",
volume = "11",
journal = "PLOS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

Bird, TG, Dimitropoulou, P, Turner, RM, Jenks, SJ, Cusack, P, Hey, S, Blunsum, A, Kelly, S, Sturgeon, C, Hayes, PC & Bird, SM 2016, 'Alpha-fetoprotein detection of hepatocellular carcinoma leads to a standardized analysis of dynamic AFP to improve screening based detection' PLOS One, vol. 11, no. 6, e0156801. https://doi.org/10.1371/journal.pone.0156801

Alpha-fetoprotein detection of hepatocellular carcinoma leads to a standardized analysis of dynamic AFP to improve screening based detection. / Bird, Thomas G.; Dimitropoulou, Polyxeni; Turner, Rebecca M.; Jenks, Sara J.; Cusack, Pearce; Hey, Shiying; Blunsum, Andrew; Kelly, Sarah; Sturgeon, Catharine; Hayes, Peter C.; Bird, Sheila M.

In: PLOS One, Vol. 11, No. 6, e0156801, 01.06.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Alpha-fetoprotein detection of hepatocellular carcinoma leads to a standardized analysis of dynamic AFP to improve screening based detection

AU - Bird, Thomas G.

AU - Dimitropoulou, Polyxeni

AU - Turner, Rebecca M.

AU - Jenks, Sara J.

AU - Cusack, Pearce

AU - Hey, Shiying

AU - Blunsum, Andrew

AU - Kelly, Sarah

AU - Sturgeon, Catharine

AU - Hayes, Peter C.

AU - Bird, Sheila M.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Detection of hepatocellular carcinoma (HCC) through screening can improve outcomes. However, HCC surveillance remains costly, cumbersome and suboptimal. We tested whether and how serum Alpha-Fetoprotein (AFP) should be used in HCC surveillance. Record linkage, dedicated pathways for management and AFP data-storage identified i) consecutive highly characterised cases of HCC diagnosed in 2009-14 and ii) a cohort of ongoing HCC-free patients undergoing regular HCC surveillance from 2009. These two well-defined Scottish patient cohorts enabled us to test the utility of AFP surveillance. Of 04 cases of HCC diagnosed over 6 years, 42% (129) were identified by a dedicated HCC surveillance programme. Of these 129, 47% (61) had a detectable lesion first identified by screening ultrasound (US) but 38% (49) were prompted by elevated AFP. Despite pre-HCC diagnosis AFP >20kU/L being associated with poor outcome, 'AFP-detected' tumours were offered potentially curative management as frequently as 'US-detected' HCCs; and had comparable survival. Linearity of serial log10 -transformed AFPs in HCC cases and in the screening 'HCC-free' cohort (n = 1509) provided indicators of high-risk AFP behaviour in HCC cases. An algorithm was devised in static mode, then tested dynamically. A case/control series in hepatitis C related disease demonstrated highly significant detection (p-5) of patients at high risk of developing HCC. These data support the use of AFP in HCC surveillance. We show proof-of-principle that an automated and further refineable algorithmic interpretation of AFP can identify patients at higher risk of HCC. This approach could provide a cost-effective, user-friendly and much needed addition to US surveillance.

AB - Detection of hepatocellular carcinoma (HCC) through screening can improve outcomes. However, HCC surveillance remains costly, cumbersome and suboptimal. We tested whether and how serum Alpha-Fetoprotein (AFP) should be used in HCC surveillance. Record linkage, dedicated pathways for management and AFP data-storage identified i) consecutive highly characterised cases of HCC diagnosed in 2009-14 and ii) a cohort of ongoing HCC-free patients undergoing regular HCC surveillance from 2009. These two well-defined Scottish patient cohorts enabled us to test the utility of AFP surveillance. Of 04 cases of HCC diagnosed over 6 years, 42% (129) were identified by a dedicated HCC surveillance programme. Of these 129, 47% (61) had a detectable lesion first identified by screening ultrasound (US) but 38% (49) were prompted by elevated AFP. Despite pre-HCC diagnosis AFP >20kU/L being associated with poor outcome, 'AFP-detected' tumours were offered potentially curative management as frequently as 'US-detected' HCCs; and had comparable survival. Linearity of serial log10 -transformed AFPs in HCC cases and in the screening 'HCC-free' cohort (n = 1509) provided indicators of high-risk AFP behaviour in HCC cases. An algorithm was devised in static mode, then tested dynamically. A case/control series in hepatitis C related disease demonstrated highly significant detection (p-5) of patients at high risk of developing HCC. These data support the use of AFP in HCC surveillance. We show proof-of-principle that an automated and further refineable algorithmic interpretation of AFP can identify patients at higher risk of HCC. This approach could provide a cost-effective, user-friendly and much needed addition to US surveillance.

KW - Alpha-Fetoprotein detection (AFP)

KW - hepatocellular carcinoma (HCC)

KW - HCC surveillance

UR - http://www.scopus.com/inward/record.url?scp=84976382157&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0156801

DO - 10.1371/journal.pone.0156801

M3 - Article

VL - 11

JO - PLOS One

T2 - PLOS One

JF - PLOS One

SN - 1932-6203

IS - 6

M1 - e0156801

ER -